HIGHLIGHTS
- who: Yinan Ding from the (UNIVERSITY) have published the research work: Application of lipid nanovesicle drug delivery system in cancer immunotherapy, in the Journal: (JOURNAL)
- what: The authors focus on the recent advances in lipid nanovesicle drug delivery systems (LNDDSs) in cancer immunotherapy and from these cutting-edge studies, the authors analyze the current challenges and future perspectives of LNDDS for translational in cancer immunotherapy (Fig 2). This study demonstrated that NK-NPs can target to cancer cells and enhance M1-macrophage polarization by NK cell membrane to produce anticancer immunity. If the authors attempt . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.